Perform Another (Advanced) Search

1. Advanced/Specific Search Results Viracept [nelfinavir]
...Advanced/Specific Search Results Viracept [nelfinavir] Clinical Trial Results: Viracept [nelfinavir] Product Name: Viracept [nelfinavir] Date of Report: 7/1/2003 Phase: III Investigation of the ...
View Page

2. Clinical Trial Results by Drug Names
...Open, multicenter, randomized, treatment simplification study to evaluate the pharmacological efficacy and safety of a nelfinavir-ritonavir combination one/day (OD) in comparison to nelfinavir twice/day (BID), using the new formulation of nelfinavir 625 mg in HIV-1 patients ...
View Page

3.  Study Posting (2246) Trial #89595, Sarcoma, Duarte, CA
...Posting (2246) Trial #89595, Sarcoma, Duarte, CA Trial Information A Phase I/II Study of Nelfinavir in Liposarcoma You have been asked to participate in this research study because you have ...
...dose (MTD, highest dose that can be given without unmanageable side effects) of the drug nelfinavir; to measure Nelfinavir levels in the blood at each dose; to evaluate tumor response (whether ...
View Page

4.  Newly Approved Drug Therapies (242) VIRACEPT (nelfinavir mesylate), Agouron Pharmaceuticals,
...Newly Approved Drug Therapies (242) VIRACEPT (nelfinavir mesylate), Agouron Pharmaceuticals, Drug Information The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: VIRACEPT (nelfinavir mesylate) Company: Agouron Pharmaceuticals Approval Status: Approved March 1997 Treatment Area: HIV infection General Information ...
View Page

5. Clinical Trial Results by Drug Names
...Study: Investigation of the gastrointestinal tolerability of a new Roche 625 mg formulation of Viracept (nelfinavir) in subjects with HIV-1 infection. Fast Facts: Protocol number: WV16789 Sponsor: Hoffman-La Roche Inc Company division: Pharmaceutical Product name: Viracept Generic name: nelfinavir Phase of development: III Therapeutic area, approved indication: HIV infection Date of report: 7/1 ...
View Page

6. Clinical Trial Results by Drug Names
...Results by Drug Names Clinical Trial Result Information Title of Study: Expanded access program of nelfinavir mesylate new formulation 625 mg in patients with HIV infection. Fast Facts: Protocol number: ML17684 Sponsor: Roche S.p.A. Company division: Pharmaceutical Product name: Viracept Generic name: nelfinavir Phase of development: III Therapeutic area, approved indication: HIV Infections Date of report: 5/1 ...
View Page

7.  Study Posting (4519) Trial #96697, HIV Infections, London, United Kingdom
...Posting (4519) Trial #96697, HIV Infections, London, United Kingdom Trial Information A Study of Viracept (Nelfinavir) in Patients With HIV-1 Infection Status: Completed Protocol Number: WV16789 Sponsor: Hoffmann-La Roche ...
...This study will assess the gastrointestinal tolerability and acceptability of a new formulation of Viracept (nelfinavir) in patients with HIV-1 infection. Patients either naive or experienced to nelfinavir treatment will ...
View Page

8.  Study Posting (4519) Trial #147948, HIV Infections, Zürich, Switzerland
...Study Posting (4519) Trial #147948, HIV Infections, Zürich, Switzerland Trial Information A Study of Viracept (Nelfinavir) in Patients With HIV-1 Infection Status: Completed Protocol Number: WV16789 Sponsor: Hoffmann-La Roche ...
...This study will assess the gastrointestinal tolerability and acceptability of a new formulation of Viracept (nelfinavir) in patients with HIV-1 infection. Patients either naive or experienced to nelfinavir treatment will ...
View Page

9.  Study Posting (4519) Trial #105207, HIV Infections, Lausanne, Switzerland
...Study Posting (4519) Trial #105207, HIV Infections, Lausanne, Switzerland Trial Information A Study of Viracept (Nelfinavir) in Patients With HIV-1 Infection Status: Completed Protocol Number: WV16789 Sponsor: Hoffmann-La Roche ...
...This study will assess the gastrointestinal tolerability and acceptability of a new formulation of Viracept (nelfinavir) in patients with HIV-1 infection. Patients either naive or experienced to nelfinavir treatment will ...
View Page

10.  Study Posting (4519) Trial #147351, HIV Infections, Madrid, Spain
...Study Posting (4519) Trial #147351, HIV Infections, Madrid, Spain Trial Information A Study of Viracept (Nelfinavir) in Patients With HIV-1 Infection Status: Completed Protocol Number: WV16789 Sponsor: Hoffmann-La Roche ...
...This study will assess the gastrointestinal tolerability and acceptability of a new formulation of Viracept (nelfinavir) in patients with HIV-1 infection. Patients either naive or experienced to nelfinavir treatment will ...
View Page

11.  Study Posting (4519) Trial #147348, HIV Infections, Barcelona, Spain
...Study Posting (4519) Trial #147348, HIV Infections, Barcelona, Spain Trial Information A Study of Viracept (Nelfinavir) in Patients With HIV-1 Infection Status: Completed Protocol Number: WV16789 Sponsor: Hoffmann-La Roche ...
...This study will assess the gastrointestinal tolerability and acceptability of a new formulation of Viracept (nelfinavir) in patients with HIV-1 infection. Patients either naive or experienced to nelfinavir treatment will ...
View Page

12.  Study Posting (4519) Trial #104209, HIV Infections, Warszawa, Poland
...Study Posting (4519) Trial #104209, HIV Infections, Warszawa, Poland Trial Information A Study of Viracept (Nelfinavir) in Patients With HIV-1 Infection Status: Completed Protocol Number: WV16789 Sponsor: Hoffmann-La Roche ...
...This study will assess the gastrointestinal tolerability and acceptability of a new formulation of Viracept (nelfinavir) in patients with HIV-1 infection. Patients either naive or experienced to nelfinavir treatment will ...
View Page

13.  Study Posting (4519) Trial #98689, HIV Infections, Mexico City, Mexico
...Posting (4519) Trial #98689, HIV Infections, Mexico City, Mexico Trial Information A Study of Viracept (Nelfinavir) in Patients With HIV-1 Infection Status: Completed Protocol Number: WV16789 Sponsor: Hoffmann-La Roche ...
...This study will assess the gastrointestinal tolerability and acceptability of a new formulation of Viracept (nelfinavir) in patients with HIV-1 infection. Patients either naive or experienced to nelfinavir treatment will ...
View Page

14.  Study Posting (4519) Trial #103925, HIV Infections, Milano, Italy
...Study Posting (4519) Trial #103925, HIV Infections, Milano, Italy Trial Information A Study of Viracept (Nelfinavir) in Patients With HIV-1 Infection Status: Completed Protocol Number: WV16789 Sponsor: Hoffmann-La Roche ...
...This study will assess the gastrointestinal tolerability and acceptability of a new formulation of Viracept (nelfinavir) in patients with HIV-1 infection. Patients either naive or experienced to nelfinavir treatment will ...
View Page

15.  Study Posting (4519) Trial #112249, HIV Infections, München, Germany
...Study Posting (4519) Trial #112249, HIV Infections, München, Germany Trial Information A Study of Viracept (Nelfinavir) in Patients With HIV-1 Infection Status: Completed Protocol Number: WV16789 Sponsor: Hoffmann-La Roche ...
...This study will assess the gastrointestinal tolerability and acceptability of a new formulation of Viracept (nelfinavir) in patients with HIV-1 infection. Patients either naive or experienced to nelfinavir treatment will ...
View Page

16.  Study Posting (4519) Trial #98215, HIV Infections, Bonn, Germany
...Study Posting (4519) Trial #98215, HIV Infections, Bonn, Germany Trial Information A Study of Viracept (Nelfinavir) in Patients With HIV-1 Infection Status: Completed Protocol Number: WV16789 Sponsor: Hoffmann-La Roche ...
...This study will assess the gastrointestinal tolerability and acceptability of a new formulation of Viracept (nelfinavir) in patients with HIV-1 infection. Patients either naive or experienced to nelfinavir treatment will ...
View Page

17.  Study Posting (4519) Trial #96626, HIV Infections, Berlin, Germany
...Study Posting (4519) Trial #96626, HIV Infections, Berlin, Germany Trial Information A Study of Viracept (Nelfinavir) in Patients With HIV-1 Infection Status: Completed Protocol Number: WV16789 Sponsor: Hoffmann-La Roche ...
...This study will assess the gastrointestinal tolerability and acceptability of a new formulation of Viracept (nelfinavir) in patients with HIV-1 infection. Patients either naive or experienced to nelfinavir treatment will ...
View Page

18.  Study Posting (4519) Trial #97405, HIV Infections, Paris, France
...Study Posting (4519) Trial #97405, HIV Infections, Paris, France Trial Information A Study of Viracept (Nelfinavir) in Patients With HIV-1 Infection Status: Completed Protocol Number: WV16789 Sponsor: Hoffmann-La Roche ...
...This study will assess the gastrointestinal tolerability and acceptability of a new formulation of Viracept (nelfinavir) in patients with HIV-1 infection. Patients either naive or experienced to nelfinavir treatment will ...
View Page

19.  Study Posting (4519) Trial #97361, HIV Infections, Montpellier, France
...Study Posting (4519) Trial #97361, HIV Infections, Montpellier, France Trial Information A Study of Viracept (Nelfinavir) in Patients With HIV-1 Infection Status: Completed Protocol Number: WV16789 Sponsor: Hoffmann-La Roche ...
...This study will assess the gastrointestinal tolerability and acceptability of a new formulation of Viracept (nelfinavir) in patients with HIV-1 infection. Patients either naive or experienced to nelfinavir treatment will ...
View Page

20.  Study Posting (4519) Trial #96607, HIV Infections, Lyon, France
...Study Posting (4519) Trial #96607, HIV Infections, Lyon, France Trial Information A Study of Viracept (Nelfinavir) in Patients With HIV-1 Infection Status: Completed Protocol Number: WV16789 Sponsor: Hoffmann-La Roche ...
...This study will assess the gastrointestinal tolerability and acceptability of a new formulation of Viracept (nelfinavir) in patients with HIV-1 infection. Patients either naive or experienced to nelfinavir treatment will ...
View Page